Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

The collaboration between Sanofi and Kymera Therapeutics on SAR444656 may represent a significant opportunity for competition ...

The risk to the general public from bird flu is low, and there has been no further evidence of person to person spread, ...

We recently compiled a list of the Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires. In this article, ...

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

In this piece, we will look at the stocks that Jim Cramer recently discussed.

Georgia officials halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 ...

The U.S. Department of Health and Human Services (HHS) revealed a major $590 million investment in Moderna to accelerate the ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

To address the rising bird flu cases, the US government has committed $590 million to fast-track Moderna's mRNA bird flu ...